PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
1 clinical trials · Condition
◉ Watch PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
| Record | Firm | Date |
|---|---|---|
| A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM) (NCT05885412) | Rocket Pharmaceuticals Inc. | 2023-08-29 |
Track PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) automatically
Every clearance here is in the API, with alerts when new ones post.